SCIENTIFIC REPORT

Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use

J García-Arumí^1,2, A Boixadera¹, J Giralt¹, V Martinez-Castillo¹, F Gomez-Ulla³, B Corcostegui² and E García-Arumí¹

¹ Vall d’Hebrón Hospital, Universidad Autónoma de Barcelona, Barcelona, Spain
² Instituto de Microcirugía Ocular, Barcelona, Spain
³ The Provincial de Conxo Hospital, Santiago de Compostela, Spain

Correspondence to:
Correspondence to:
Dr J García Arumí
Instituto de Microcirugía Ocular, C/Munner n° 10, 08022, Barcelona, Spain; 17215jga{at}comb.es

Background: Intravitreal triamcinolone has increasingly been used for the treatment of oedematous and neovascular diseases and purification of triamcinolone suspension may be important in order to avoid the potential toxic effects of the vehicle. The aim was to evaluate different techniques used to reduce the solvent agent benzyl alcohol (9.9 mg/ml) from a commercially prepared triamcinolone acetonide suspension.

Methods: Different techniques were used to reduce the solvent agent benzyl alcohol: filter techniques using 0.22 µm or 5 µm pore size, and non-filter techniques using sedimentation or centrifugation. Quantification of triamcinolone acetonide and benzyl alcohol was performed by high pressure liquid chromatography (HPLC).

Results: Benzyl alcohol concentration was decreased significantly in all the techniques used compared with the original commercial suspension (p<0.05), with no significant differences among them. The reduction was approximately one tenth of its original concentration. However, triamcinolone acetonide concentration differed significantly depending on the method used. Centrifugation method showed no differences versus the original commercial solution; sedimentation technique reduced the expected dose only 25%; the filter technique using a 5 µm pore size membrane reduced the expected dose to one fourth, while the filter technique using a 0.22 µm pore size membrane reduced the expected dose to 45%.

Conclusions: All the different techniques employed effectively reduced the concentration of benzyl alcohol. However, the final concentration of triamcinolone was much lower than expected using the filter techniques. The pore size membrane inversely influenced the final concentration, with part of the triamcinolone crystals probably being entrapped in the filter. Centrifugation is recommended as the best way of administering the drug.

Abbreviations: BSS, balanced salt solution; HPLC, high pressure liquid chromatography

Keywords: triamcinolone acetonide suspension; intravitreal injection

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

BJO at a glance

Creig Hoyt
Br. J. Ophthalmol. 2005 89: 1073a. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Veritti, D., Lanzetta, P., Perissin, L., Bandello, F. (2009). Posterior Juxtascleral Infusion of Modified Triamcinolone Acetonide Formulation for Refractory Diabetic Macular Edema: One-Year Follow-Up. IOVS 50: 2391-2397 [Abstract] [Full Text]  
• Tammewar, A M, Cheng, L, Kayikcioglu, O R, Falkenstein, I A, Kozak, I, Goldbaum, M H, Freeman, W R (2008). Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections. Br. J. Ophthalmol. 92: 810-813 [Abstract] [Full Text]  
• Lorenzo Carrero, J., Gonzalez Barcia, M., Perez Flores, I. (2008). Sterile Endophthalmitis After Benzyl Alcohol Filtered Triamcinolone Acetonide Injection. Arch Ophthalmol 126: 142-143 [Full Text]  
• Chang, Y.-S., Wu, C.-L., Tseng, S.-H., Kuo, P.-Y., Tseng, S.-Y. (2007). Cytotoxicity of Triamcinolone Acetonide on Human Retinal Pigment Epithelial Cells. IOVS 48: 2792-2798 [Abstract] [Full Text]  
• Hartnett, M. E., Martiniuk, D. J., Saito, Y., Geisen, P., Peterson, L. J., McColm, J. R. (2006). Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy. IOVS 47: 4975-4982 [Abstract] [Full Text]  
• Soto-Pedre, E. (2006). Purification of triamcinolone acetonide suspension for intravitreal injection. Br. J. Ophthalmol. 90: 123-124 [Full Text]